🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

MCW Urology is expanding - we are accepting applications for an additional PGY2 position to start July 1, 2024. Candidates must have completed a PGY-1 year in Urology or Surgery prior to July 1, with a minimum 3 months of clinical Uro.

Finally, the long-awaited TRAVERSE Prostate Safety Study has just been released. During 14,304 person-years of follow-up on 5204 men (aged 45-80 years) with hypogonadism in this randomized clinical trial, incidences of high-grade or any prostate cancer, acute urinary retention,

Pure class from Costco management

Who is changing healthcare this new year ? Mark Cuban Cost Plus Drug Company is ! let's get it started with another price drop ! And don't forget we now carry more than 2024 meds !

My sense is some men choose surgery over RT due to concerns over secondary malignancy. If you discuss secondary malignancies of RT (as I do), be fair and explain it appears to be an absolute risk of 0.5-1% at 25 years (many docs don't give risk estimate) auajournals.org/doi/full/10.10…

We are so excited to welcome our newest UVA Urology residents! 🎉🙌 Congratulations, and happy Match Day to all! #uva #uvaurology #uromatch2024

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8

Enfortumab vedotin plus pembrolizumab treatment represents a paradigm shift in the management of advanced urothelial cancer, based on results of a new NEJM study. jwat.ch/48JFji7 #MedTwitter

Among patients with advanced urothelial cancer, 5-year survival with first-line platinum-based chemotherapy is relatively low. Enfortumab vedotin plus pembrolizumab may improve outcomes. Research findings are summarized in a new Quick Take video. youtu.be/9XZseJ7csOY

Original Article: Microplastics and Nanoplastics in Atheromas and Cardiovascular Events nej.md/3IrM6T8 Editorial: Plastics, Fossil Carbon, and the Heart nej.md/48CvGSs #PublicHealth

A beautiful tribute in PNAS by Dr. Doug Lowy on Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer. pnas.org/doi/10.1073/pn…

ABU announces the launch of Continuing Urologic Certification (CUC). Please log onto your Diplomate portal at portal.abu.org to view this year's requirements. Additional information can be found on the ABU website abu.org.

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8 #PublicHealth

Patients with sentinel-node metastasis at the time of breast-cancer surgery may undergo axillary dissection to remove more nodes, which can lead to side effects. In the SENOMAC trial, the additional surgery did not prolong survival. Full trial results: nej.md/3PNRGD9

Most oncology drugs granted accelerated approval did not demonstrate OS benefit or improve QOL within 5 years of approval Need better correlation of surrogate endpoints with what actually matters to patients jamanetwork.com/journals/jama/… JAMA Oncology IBCG #EAU24 #AACR24

Michael Gorin, M.D. There’s no mandated dress code at the AUA meeting.

🔥Just published in Journal of Urology 1️⃣The first US RCT on prophylactic mesh in ileal conduit led by Dr. Hooman Djaladat (2015-2023) ▶️Biologic mesh placement is feasible with no AEs ▶️No protective effect within 2yr FU 🔗auajournals.org/doi/10.1097/JU… Amer. Urol. Assn. USC Urology Radiology of USC

KEYNOTE-564 trial: Improved survival in renal-cell cancer after 1 year of adjuvant therapy was seen with pembrolizumab. At 4 years, 91% of pembrolizumab-treated patients were alive, as compared with 86% of those who received placebo after surgery. nej.md/3TVLuKz

Happy to announce this collaboration between UVA Surgery and UVA Urology for qualified candidates. Let’s find a match Charles Friel Kirsten Greene #urologymatch2025

I learned some cool stuff at the AUA other than craps 🎲. Here are some things I found interesting #AUA25 🎰 1. Vesical mucosa grafts instead of buccal for ureteroplasty. Italian group with success in all 14 patients. With some muscle backing behind it seems ideal.